1291 results found
In 2017–18, almost 1 million Australian adults had type 2 diabetes (T2D) and, in 2018, diabetes contributed to 11% of, or over 17,000, Australian deaths.1,2 Cardiovascular disease is the primary cause of death for people with diabetes and obesity is a major contributor to the disease.3
The Indigenous Advisory Group (IAG) provides strategic advice on Aboriginal and Torres Strait Islander health and health research issues.
Dr Tafi Marukutira is a medical doctor and public health researcher, specialising in infectious diseases epidemiology. Dr Marukutira received the 2022 NHMRC Frank Fenner Investigator Grant Award (Emerging Leadership), which recognises the highest ranked recipient in the Emerging Leadership Level 1 Investigator Grant category within the Basic Science or Public Health research areas, for his work on equitable access to HIV care and treatment.
10 of the Best 2014 describes 10 Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia.
NHMRC recognises excellence in the health and medical research sector through its annual Research Excellence Awards. Find our 2023 award winners listed below.
The Consumer Advisory Group (CAG) provides strategic advice on health matters and health and medical research matters from a consumer perspective.
NHMRC opened a Targeted Call for Research (TCR) into Debilitating Symptom Complex Attributed to Ticks on 30 May 2018. Given the public interest in the call following the Senate Inquiry and the government’s response to fund further research on this issue, NHMRC decided to re-open the call to accept additional applications to ensure that a breadth of the highest quality research is funded. The extended call for applications closed on 29 August 2018.
CEO Communique – February 2022
Leukaemias are difficult-to-treat blood cancers, which are common among both young and older people. In Australia in 2023, around 20,000 people were diagnosed with a blood cancer and blood cancers accounted for an estimated 38% of all cancer cases among the 0–19 year-old age group. Over 5,000 Australians die each year from blood cancers.1 NHMRC-funded researchers at WEHI have made revolutionary breakthroughs in our understanding of leukaemia biology, leading to the development of a new type of anti-cancer drug, venetoclax, that has significantly improved treatment for leukaemia patients.
The Melbourne Academic Centre for Health is an NHMRC-accredited Research Translation Centre. We collaborate to deliver research-informed healthcare and training. The below case studies highlight our work in translating research into better health outcomes and building capability across the system.